ICU Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

SeaStar Medical Holding Corp | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerICU

Market Cap14.7M

Cash RunwayRunway 6-12 months

Next Catalystn/a

Public Research Snapshot

SeaStar Medical Holding Corp is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for An alarmingly urgent situation (Approved).

Pipeline

Asset	Indication	Modality	Stage	Public Note
An alarmingly urgent situation	n/a	n/a	Approved	Public pipeline row
Better outcomes	transforming treatments for critically ill patients facing organ failure and potential loss of life	n/a	Approved	Public pipeline row
Adult AKI and CRRT	n/a	n/a	Pivotal	Public pipeline row

Catalyst Preview

No public catalyst rows matched this view yet.

Cash Runway Preview

Estimated cash runway: Runway 6-12 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

No public filing rows are loaded yet.

Clinical Trial Activity

NCT ID	Phase	Status	Enrollment	Primary Completion
No public trial rows are loaded yet.

Scientific Context

literature_publication | Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.
literature_publication | Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
asset_name | Adult AKI and CRRT
asset_name | Adult AKI and CRRT
asset_name | Adult AKI and CRRT

Want the full ICU research brief?

Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.

Get the weekly biotech catalyst watchlist

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.